Johns Hopkins Ciccarone Center

Breakthroughs in Preventive Cardiology: Key Clinical Trials of 2024 #cvprev @MichaelJBlaha @rblument1

New in @AJPCardio by the Ciccarone team and colleagues; Burka, Aneni, Leucker & Blaha; a paradigm-shifting proposal reshaping the future of ACC/AHA cholesterol and prevention guidelines ow.ly/TlQb50WhhuB 🔄 Reframes 2022 ACC/ECDP Fig. 6 📉 LDL-C targets tied to CAC burden…

Self-Reported Resilience During the COVID-19 Pandemic jamanetwork.com/journals/jaman… - Neat paper by Drs. Bunmi Ogungbe & @WendyPost9 + @NadiaHanselMD & all-star team @CiccaroneCenter

Nice review/editorial led by 🌟 UMd med student @zehraanum14 summarizing our recent paper in @JACCJournals re: distribution of CAC score in South Asian adults @SaurabhSDani @AAgarwalaMD @alka_kanaya @ACCmediacenter @CiccaroneCenter 🔗 acc.org/latest-in-card…

Happy to be a contributing author on this review discussing the role of Lp(a) in South Asian adults, led by @DineshKalra We review data on Lp(a) in mediating ASCVD, epidemiology in SA, screening guidelines, & meds to reduce Lp(a)/associated CVD risk 🔗 ahajournals.org/doi/10.1161/JA…

For patients who can’t tolerate statins, or need more LDL-C lowering despite high-intensity therapy, bempedoic acid is a proven option that’s often overlooked. Quick read our case 🔗 @ACCinTouch learn.acc.org/Page/Bempedoic…

Ever wondered how the 🫀 affects the 🧠 ? Join us this afternoon for an interactive session with Dr Michelle Johansen as she tells us about her NOMINATE study!

Faculty-fellow mentoring beyond the hospital walls!

Amazing review by @RayaniAsma looking at the possible impact of the new PREVENT equations on statin use and how PREVENT may change preventive interventions @GarimaVSharmaMD @ISHVnews @CiccaroneCenter rdcu.be/euyOv

#cvPrev #hypertension @CiccaroneCenter @rblument1 @seamuswhelton @AAgarwalaMD @DrEugeneYang @EugeniaGianos @johnwmcevoy @ACCmediacenter

Is It Time For a New Blood Pressure Treatment Goal? Led by ⁦@OslerResidency⁩ ⭐️ Dr. Akwasi Aduboffour ⁦@seamuswhelton⁩ ⁦@CiccaroneCenter⁩ #🥍🫀🎾⚾️🏊🏼‍♀️🏃‍♀️🏈⛳️ acc.org/Latest-in-Card…

Kicking off the first day of fellowship! We are thrilled to welcome such a talented group of fellows and look forward to seeing what they will accomplish this year! 🎉

The past 12 months mark a milestone year for sports and exercise cardiology, Drs. Kellen Alexander Knowles and @LiliBarouch write in a new Commentary   👇Read their recap below healio.com/news/cardiolog…   #SportsCardiology @HopkinsHeart @CiccaroneCenter

LDL-C Targets Based on Coronary Calcium: Advancing Figure 6 from the ACC Expert Consensus Decision Pathway - insightful article by Drs. Seme Burka, Ehimen Aneni, ⁦@TLeucker⁩ ⁦@MichaelJBlaha⁩ ⁦@CiccaroneCenter⁩ #🥍🫀⚽️⚾️🎾🏊🏼‍♀️🏃‍♀️🏀 sciencedirect.com/science/articl…

📝 New AJPC Commentary: “LDL-C Targets Based on Coronary Artery Calcium” explores updates to Figure 6 from the 2022 ACC Expert Consensus Decision Pathway, pushing preventive strategies forward. ow.ly/TlQb50WhhuB #PreventiveCardiology #LDLC #CoronaryCalcium #ACC #AJPC

New rescued baby Blue Jay. Fell from the nest last night.

We all agree that #BMI is outdated for defining #obesity. How does the new definition of clinical and preclinical obesity compare to the good old BMI in a large population-based cohort? Do not miss our newest article @TheLancetEndo led by our 🌟 @yao_zhiqi @CiccaroneCenter

2/5 ⚠️We cross-checked the new definition with the widely adopted WHO BMI-only categories, and found major gaps. Even among those with normal or overweight BMI: 🔸 Normal weight: 11.3% had preclinical obesity, 11.0% had clinical obesity 🔸 Overweight: 31.8% had preclinical…

3/5📌 BMI ≠ the full story. Preclinical and clinical obesity span all BMI categories, not just those with high BMI. Among those with: 🟧 Preclinical obesity ▪️ 10.2% were normal weight ▪️ 33.0% overweight ▪️ 56.8% Class 1–3 obesity 🔴 Clinical obesity ▪️ 7.3% normal weight ▪️…